Chemed Reports Q3 2026 Results, Updates EPS Outlook
Chemed reported revenue of $690.9 million and adjusted EPS of $6.75 for the quarter ended September 30, 2026. Roto-Rooter revenue rose 7.5% to $233.5 million year over year. The company now expects 2026 adjusted EPS at or slightly above the high end of its previous $25.00–$25.75 range.